NHS Confederation and ABPI Report Recommends Collaboration to Increase Access to Innovative Therapeutics

A newly published report from the NHS Confederation and Association of the British Pharmaceutical Industry (ABPI) indicates that collaboration between the NHS and pharma can help improve patient access to innovative treatments. The report noted that uptake of novel therapeutics was often stunted by a variety of barriers, systemic and situational. However, some examples of effective partnerships were discussed.

According to Nicole Raleigh, “Highlighting four initiatives where effective partnerships between the NHS, patient organisations, and industry have helped tackle the unwarranted variation in uptake, the report evidences where the NHS has been able to have time in hospital for patients with certain cancers, freeing up clinical time to reduce the backlog of care. Referrals for treatment for people with lung cancer from some of the most deprived areas, for instance, have improved, and diabetes patient waiting times have reduced.”

To read more, click here.

(Source: PharmaPhorum, January 17th, 2023)